Publications

5808 Results

Phase II evaluation of merbarone in disseminated malignant melanoma: A Southwest Oncology Group study.

Authors
M Slavik;PY Liu;E Kraut;R Natale;V Sondak
Journal / Conference
ASCO 13:398(#1357)
Year
1994
Research Committee(s)
Melanoma
Study Number(s)
SWOG-8913

Cisplatin (P) & etoposide (E) + concurrent thoracic radiotherapy (TRT) administered once versus twice daily for limited-stage (LS) small cell lung cancer (SCLC): Preliminary results of an intergroup trial.

Authors
DH Johnson;K Kim;AT Turrisi;W Sause;R Komaki;H Wagner;R Blum
Journal / Conference
ASCO 13:333(#1105)
Year
1994
Research Committee(s)
Lung
Study Number(s)
SWOG-9252 (INT-0115) (EST-3590) (RTOG 91-05) (NCCTG-91-24-51) (CALGB-9393)

Trisomy II in acute myeloid leukemia: a non-random chromosomal aberration associated with a stem cell phenotype.

Authors
ML Slovak;K Kopecky;RE Magenis;D Head;FR Appelbaum;C Willman
Journal / Conference
American Association for Cancer Research 35:194(#1160)
Year
1994

Analysis of Southwest Oncology Group (SWOG) accrual for sex ratios and associated socioeconomic status (SES) factors.

Authors
L Hutchins;D Rector;C Stotts;S Dahlberg;CA Coltman;K Albain
Journal / Conference
ASCO 13:188(#539)
Year
1994

Treatment outcome with chemotherapy in acute promyelocytic leukemia: the Southwest Oncology Group (SWOG) experience.

Authors
DR Head;KJ Kopecky;C Willman;FR Appelbaum
Journal / Conference
Leukemia 8(Suppl.2):S38-S41
Year
1994
Research Committee(s)
Leukemia
Study Number(s)
SWOG-8124/25/26, SWOG-8522, SWOG-8561, SWOG-8600, SWOG-8706

Combination chemotherapy, glucocorticoids, and interferon alfa in the treatment of multiple myeloma: A Southwest Oncology Group study

Authors
SE Salmon;JJ Crowley;TM Grogan;P Finley;RP Pugh;B Barlogie
Journal / Conference
Journal of Clinical Oncology 12(11):2405-2414
Year
1994
Research Committee(s)
Myeloma
Study Number(s)
SWOG-8624

Adjuvant CMFVP versus tamoxifen versus concurrent CMFVP and tamoxifen for postmenopausal, node-positive and estrogen receptor-positive breast cancer patients: A Southwest Oncology Group study

Authors
SE Rivkin;S Green;B Metch;AB Cruz;MD Abeloff;WR Jewell;JJ Costanzi;WB Farrar;JP Minton;CK Osborne
Journal / Conference
Journal of Clinical Oncology 12(10):2078-2085
Year
1994
Research Committee(s)
Breast
Study Number(s)
SWOG-7827

Phase II trial of didemnin B (DNB) in patients (pts) with recurrent or residual malignant gliomas

Authors
SA Taylor;C Upchurch;C Schold
Journal / Conference
Annals of Oncology 5(Suppl.5)(#280)
Year
1994
Research Committee(s)
Brain
Study Number(s)
SWOG-9110

A Southwest Oncology Group phase II evaluation of fludarabine monophosphate in sarcoma.

Authors
MR Grever;J Benedetti;SP Balcerzak;SA Taylor;TP Miller;SR Dakhil
Journal / Conference
Investigational New Drugs 12:259-261
Year
1994
Research Committee(s)
Sarcoma
Study Number(s)
SWOG-8322

A phase III comparison of CHOP vs. m-BACOD vs. ProMACE-CytaBOM vs. MACOP-B in patients with intermediate- or high-grade non-Hodgkin's lymphoma: Results of SWOG-8516 (Intergroup 0067), the national high-priority lymphoma study

Authors
RI Fisher;ER Gaynor;S Dahlberg;MM Oken;TM Grogan;EM Mize;JH Glick;CA Coltman;TP Miller
Journal / Conference
Annals of Oncology 5(Suppl.2):S91-S95
Year
1994
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8516 (INT-0067)